Intranasal immunization of BALB/c strain mice was carried out using baculov
irus-derived human chorionic gonadotrophin (hCG) beta -chain, together with
Escherichia coli heat-labile enterotoxin. Gonadotrophin-reactive immunoglo
bulin A (IgA) was induced in a remote mucosal site, the lung, in addition t
o a systemic IgG response. The extensive sequence homology with luteinizing
hormone (LH) results in the production of LH cross-reactive antibodies whe
n holo-hCG is used as an immunogen. In contrast to wild-type hCG beta, a mu
tated hCG beta -chain containing an arginine to glutamic acid substitution
at position 68 did not induce the production of antibodies which cross-reac
t with LH. Furthermore, the epitopes utilized in the B-cell response to the
mutated hCG beta shifted away from the immunodominant region of the parent
wild-type molecule towards epitopes within the normally weakly immunogenic
C terminus. This shift in epitope usage was also seen following intramuscu
lar immunization of rabbits. Thus, a single amino acid change, which does n
ot disrupt the overall structure of the molecule, refocuses the immune resp
onse away from a disadvantageous cross-reactive epitope region and towards
a normally weakly immunogenic but antigen-unique area. Similar mutational s
trategies for epitope-refocusing may be applicable to other vaccine candida
te molecules.